These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8702435)

  • 1. Expression and function of CD80 and CD86 costimulator molecules on synovial dendritic cells in chronic arthritis.
    Summers KL; O'Donnell JL; Williams LA; Hart DN
    Arthritis Rheum; 1996 Aug; 39(8):1287-91. PubMed ID: 8702435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis.
    Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS
    Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
    McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
    Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
    Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J
    J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of CD80 and CD86 on T cell cytokine production.
    Petro TM; Chen SS; Panther RB
    Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity.
    Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S
    Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy.
    Sfikakis PP; Via CS
    Clin Immunol Immunopathol; 1997 Jun; 83(3):195-8. PubMed ID: 9175907
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis.
    Truneh A; Reddy M; Ryan P; Lyn SD; Eichman C; Couez D; Hurle MR; Sekaly RP; Olive D; Sweet R
    Mol Immunol; 1996 Feb; 33(3):321-34. PubMed ID: 8649453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costimulatory function of umbilical cord blood CD14+ and CD34+ derived dendritic cells.
    Dilioglou S; Cruse JM; Lewis RE
    Exp Mol Pathol; 2003 Aug; 75(1):18-33. PubMed ID: 12834622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig.
    Nishimura Y; Shimojima M; Miyazawa T; Sato E; Nakamura K; Izumiya Y; Ikeda Y; Mikami T; Takahashi E
    Eur J Immunogenet; 2000; 27(5-6):427-30. PubMed ID: 11029611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD80 expression is induced on activated B cells following stimulation by CD86.
    Sahoo NC; Rao KV; Natarajan K
    Scand J Immunol; 2002 Jun; 55(6):577-84. PubMed ID: 12028560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells.
    Dilioglou S; Cruse JM; Lewis RE
    Exp Mol Pathol; 2003 Dec; 75(3):217-27. PubMed ID: 14611813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions.
    Greene JL; Leytze GM; Emswiler J; Peach R; Bajorath J; Cosand W; Linsley PS
    J Biol Chem; 1996 Oct; 271(43):26762-71. PubMed ID: 8900156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD28/CTLA-4-B7 signaling pathway is involved in both allergic sensitization and tolerance induction to orally administered peanut proteins.
    van Wijk F; Nierkens S; de Jong W; Wehrens EJ; Boon L; van Kooten P; Knippels LM; Pieters R
    J Immunol; 2007 Jun; 178(11):6894-900. PubMed ID: 17513738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional CD86 (B7-2/B70) on cultured human Langerhans cells.
    Yokozeki H; Katayama I; Ohki O; Matsunaga T; Watanabe K; Satoh T; Azuma M; Okumura K; Nishioka K
    J Invest Dermatol; 1996 Jan; 106(1):147-53. PubMed ID: 8592066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors.
    Linsley PS; Greene JL; Brady W; Bajorath J; Ledbetter JA; Peach R
    Immunity; 1994 Dec; 1(9):793-801. PubMed ID: 7534620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells.
    Zheng Y; Manzotti CN; Liu M; Burke F; Mead KI; Sansom DM
    J Immunol; 2004 Mar; 172(5):2778-84. PubMed ID: 14978077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis.
    Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK
    Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.